Medicare Enrolled
Dr. Juan Cadavid Sepulveda, MD.
Critical Care Medicine · Cumming, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Cadavid Sepulveda from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cadavid Sepulveda?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Cadavid Sepulveda
Dr. Juan Cadavid Sepulveda is a critical care medicine specialist in Cumming, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Cadavid Sepulveda performed 1,178 Medicare services across 805 unique beneficiaries.
Between the years covered by Open Payments, Dr. Cadavid Sepulveda received a total of $13,616 from 47 pharmaceutical and/or device companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Cadavid Sepulveda is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 29% volume in GA
$13,616 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,178
Medicare services
Top 29% in GA for critical care medicine
805
Unique beneficiaries
$71
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~62 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
375 | $95 | $387 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
235 | $62 | $233 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
111 | $23 | $102 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
78 | $94 | $342 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
69 | $66 | $273 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $119 | $504 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
58 | $20 | $86 |
| Airflow rate measurement test A test that measures the rate of airflow. This procedure assesses how quickly air moves. |
38 | $29 | $116 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
37 | $45 | $171 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
26 | $43 | $165 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
22 | $14 | $45 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
18 | $23 | $102 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $136 | $529 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $102 | $394 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
12 | $95 | $571 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,616
Total received (2018-2024)
Avg $1,945/year across 7 years
Top 11% in GA for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
641
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,461 (98.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$155 (1.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,831
2023
$2,168
2022
$2,521
2021
$2,275
2020
$2,088
2019
$2,177
2018
$556
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$338
GlaxoSmithKline, LLC.
$306
Boehringer Ingelheim Pharmaceuticals, Inc.
$161
Regeneron Healthcare Solutions, Inc.
$153
Takeda Pharmaceuticals U.S.A., Inc.
$149
GENZYME CORPORATION
$141
Amgen Inc.
$113
Grifols USA, LLC
$94
Insmed, Inc.
$58
Actelion Pharmaceuticals US, Inc.
$50
Mylan Specialty L.P.
$45
Philips North America LLC
$43
ANI Pharmaceuticals, Inc.
$43
Mallinckrodt Hospital Products Inc.
$31
Inspire Medical Systems, Inc.
$26
Baxter Healthcare
$26
Paratek Pharmaceuticals, Inc.
$21
United Therapeutics Corporation
$17
La Jolla Pharmaceutical Company
$16
Top 3 companies account for 44.0% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim Pharmaceuticals, Inc.
$2,306
GlaxoSmithKline, LLC.
$2,045
AstraZeneca Pharmaceuticals LP
$1,401
Actelion Pharmaceuticals US, Inc.
$1,364
Mylan Specialty L.P.
$774
Regeneron Healthcare Solutions, Inc.
$753
Takeda Pharmaceuticals U.S.A., Inc.
$470
Grifols USA, LLC
$450
GENZYME CORPORATION
$336
PFIZER INC.
$321
Insmed, Inc.
$299
Amgen Inc.
$286
Baxter Healthcare
$240
Janssen Pharmaceuticals, Inc
$229
Mallinckrodt Hospital Products Inc.
$226
United Therapeutics Corporation
$222
Advanced Respiratory, Inc
$220
JAZZ PHARMACEUTICALS INC.
$193
Electromed, Inc.
$174
Paratek Pharmaceuticals, Inc.
$128
Sunovion Pharmaceuticals Inc.
$89
ANI Pharmaceuticals, Inc.
$84
ADVANCED RESPIRATORY, INC
$75
Alexion Pharmaceuticals, Inc.
$75
PORTOLA PHARMACEUTICALS, LLC
$64
Mallinckrodt Enterprises LLC
$64
Bayer HealthCare Pharmaceuticals Inc.
$62
AbbVie Inc.
$61
La Jolla Pharmaceutical Company
$60
Teva Pharmaceuticals USA, Inc.
$58
Axsome Therapeutics, Inc.
$48
Philips North America LLC
$43
Shire North American Group Inc
$42
Merck Sharp & Dohme LLC
$40
Genentech USA, Inc.
$35
Jazz Pharmaceuticals Inc.
$33
Gilead Sciences, Inc.
$33
Resmed Corp
$30
Eisai Inc.
$30
Inspire Medical Systems, Inc.
$26
Chiesi USA, Inc.
$26
Mallinckrodt LLC
$22
Merck Sharp & Dohme Corporation
$20
Philips Electronics North America Corporation
$18
Harmony Biosciences LLC
$16
ARBOR PHARMACEUTICALS, INC.
$12
E.R. Squibb & Sons, L.L.C.
$11
Top 3 companies account for 42.2% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (AK6) Vest Therapy · ACTHAR · AIR 11 · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · Actemra · Adempas · AirDuo Digihaler · Arikayce · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CLEVIPREX · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dayvigo · Dymista · ELIQUIS · FASENRA · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · Hillrom - Volara System · Horizant · IMFINZI · INSPIRE · LONHALA MAGNAIR · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 13 · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C · Prolastin-C Liquid · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · ULTOMIRIS · UPTRAVI · Ultomiris · Utibron · Wakix · XARELTO · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
34
Per 100K population
13.1
County median income
$138,000
Nearest hospital
NORTHSIDE HOSPITAL FORSYTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Cadavid Sepulveda is a clinical cardiology specialist, with above-average Medicare volume (top 29% in GA), with low-engagement industry engagement in the top 11% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Cadavid Sepulveda experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Cadavid Sepulveda performed 375 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Cadavid Sepulveda receive payments from pharmaceutical companies?
Yes. Dr. Cadavid Sepulveda received a total of $13,616 from 47 companies across 641 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Cadavid Sepulveda's costs compare to other critical care medicines in Cumming?
Dr. Cadavid Sepulveda's average Medicare payment per service is $71. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Cadavid Sepulveda) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Cumming
Browse critical care medicines in Cumming ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in GA
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in GA
Which GA critical care medicines receive the most from drug and device companies.
By company
Boehringer Ingelheim Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim Pharmaceuticals, Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology